You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NHL (Non-Hodgkins Lymphoma)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

Not yet recruiting
  • B-cell Non-Hodgkins Lymphoma (B-NHL)
  • (no location specified)
Jan 5, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • B-cell Non Hodgkin Lymphoma
  • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
  • Aurora, Colorado
    Children's Hospital Colorado
Nov 9, 2022

Circulating Cell DNA in Pediatric Mature B Cell Non-Hodgkins

Not yet recruiting
  • Non-hodgkin Lymphoma
  • modified BFM-95 protocol
  • (no location specified)
Jul 9, 2021

Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (JBH492)

Recruiting
  • Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • Phoenix, Arizona
  • +10 more
Nov 11, 2022

Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma Trial in Japan (tafasitamab, lenalidomide, parsaclisib)

Recruiting
  • Non Hodgkins Lymphoma
  • Diffuse Large B-cell Lymphoma
  • Aichi, Japan
  • +4 more
Jan 24, 2022

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Non Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia Trial in France, United Kingdom (Tirabrutinib)

    Completed
    Has Results
    • Non Hodgkins Lymphoma
    • Chronic Lymphocytic Leukaemia
    • Lille, France
    • +5 more
    Feb 22, 2021

    NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

    Recruiting
    • NHL
    • NHL, Relapsed, Adult
    • Birmingham, Alabama
    • +4 more
    May 31, 2023

    (CHANT)Real World Study of Duvelisib in Treatment of

    Not yet recruiting
    • Follicular Lymphoma
    • +5 more
    • (no location specified)
    Jun 20, 2023

    CD20-positive Non-Hodgkin Lymphoma Trial in Seoul (Rituximab + MG4101)

    Terminated
    • CD20-positive Non-Hodgkin Lymphoma
    • Rituximab + MG4101
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Oct 24, 2022

    Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

    Recruiting
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • BAFFR-CAR T cells
    • Duarte, California
      City of Hope Medical Center
    Oct 18, 2022

    SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • +2 more
      • (no location specified)
      Jun 22, 2023

      B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

      Recruiting
      • B-cell Non-Hodgkin Lymphoma (B-NHL)
      • UCART20x22
      • CLLS52
      • Austin, Texas
        Sarah Cannon - St. David South Austin Medical Center
      Dec 8, 2022

      Non-Hodgkin's Lymphoma Trial in Hangzhou (ThisCART19A)

      Recruiting
      • Non-Hodgkin's Lymphoma
      • ThisCART19A
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Apr 21, 2022

      Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin
      • Perth, Western Australia, Australia
        Linear Clinical Research Ltd
      Apr 20, 2023

      Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

      Recruiting
      • Non-Hodgkin Lymphoma
      • Hodgkin Lymphoma
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Jan 25, 2023

      Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas Trial in Philadelphia (CART-19)

      Completed
      Has Results
      • Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas
      • CART-19
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Oct 1, 2020

      NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

      Suspended
      • NHL
      • +3 more
      • Minneapolis, Minnesota
      • +1 more
      Jan 31, 2023

      Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

      Not yet recruiting
      • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
      • (no location specified)
      Mar 23, 2023

      B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

      Not yet recruiting
      • B-cell Non-Hodgkin Lymphoma
      • +4 more
      • (no location specified)
      Dec 7, 2022

      Lymphoma, Non-Hodgkin Trial in China (DZD8586)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • Beijing, Beijing, China
      • +5 more
      Apr 25, 2023

      Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • BTK inhibitor
      • PD-1 inhibitor
      • Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      May 20, 2023

      Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

      Active, not recruiting
      • Non Hodgkin Lymphoma
      • UCD19 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022

      NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Guangzhou (GNC-038)

      Not yet recruiting
      • NK/T Cell Lymphoma
      • +2 more
      • Guangzhou, Guangdong, China
      • +1 more
      Jan 12, 2023

      Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)

      Recruiting
      • Non-hodgkin's Lymphoma
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Jan 12, 2023